相似文献
1
Association of CLU and PICALM variants with Alzheimer's disease.
Neurobiol Aging. 2012 Mar;33(3):518-21. doi: 10.1016/j.neurobiolaging.2010.04.015. Epub 2010 Jun 8.
2
Implication of common and disease specific variants in CLU, CR1, and PICALM.
Neurobiol Aging. 2012 Aug;33(8):1846.e7-18. doi: 10.1016/j.neurobiolaging.2012.01.110. Epub 2012 Mar 7.
3
The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.
Arch Gen Psychiatry. 2011 Feb;68(2):207-13. doi: 10.1001/archgenpsychiatry.2010.196.
4
Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.
Hum Mol Genet. 2010 Aug 15;19(16):3295-301. doi: 10.1093/hmg/ddq221. Epub 2010 Jun 9.
5
Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.
Alzheimers Dement. 2014 Mar;10(2):205-13. doi: 10.1016/j.jalz.2013.01.016. Epub 2013 May 2.
6
Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population.
Neurobiol Aging. 2012 Jan;33(1):210.e1-7. doi: 10.1016/j.neurobiolaging.2011.09.016. Epub 2011 Oct 19.
7
LACK OF ASSOCIATIONS BETWEEN CLU AND PICALM GENE POLYMORPHISMS AND ALZHEIMER'S DISEASE IN A TURKISH POPULATION.
Ideggyogy Sz. 2015 Mar 30;68(3-4):113-20.
8
Replication of CLU, CR1, and PICALM associations with alzheimer disease.
Arch Neurol. 2010 Aug;67(8):961-4. doi: 10.1001/archneurol.2010.147. Epub 2010 Jun 14.
9
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.
Arch Neurol. 2010 Dec;67(12):1473-84. doi: 10.1001/archneurol.2010.201. Epub 2010 Aug 9.
10
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
Nat Genet. 2009 Oct;41(10):1088-93. doi: 10.1038/ng.440. Epub 2009 Sep 6.
引用本文的文献
1
Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's disease.
Genome Biol. 2025 Jul 17;26(1):210. doi: 10.1186/s13059-025-03564-z.
2
PICALM and Alzheimer's Disease: An Update and Perspectives.
Cells. 2022 Dec 10;11(24):3994. doi: 10.3390/cells11243994.
3
Admixture mapping identifies novel Alzheimer's disease risk regions in African Americans.
Alzheimers Dement. 2023 Jun;19(6):2538-2548. doi: 10.1002/alz.12865. Epub 2022 Dec 20.
4
Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping.
Alzheimers Res Ther. 2022 Feb 4;14(1):22. doi: 10.1186/s13195-022-00962-4.
5
Genetically regulated expression in late-onset Alzheimer's disease implicates risk genes within known and novel loci.
Transl Psychiatry. 2021 Dec 6;11(1):618. doi: 10.1038/s41398-021-01677-0.
6
Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer's Disease in a Central European Population.
Neurochem Res. 2021 Feb;46(2):411-422. doi: 10.1007/s11064-020-03176-y. Epub 2020 Nov 18.
7
Involvement of Lipids in Alzheimer's Disease Pathology and Potential Therapies.
Front Physiol. 2020 Jun 9;11:598. doi: 10.3389/fphys.2020.00598. eCollection 2020.
8
Complement receptor 1 genetic polymorphism contributes to sporadic Alzheimer's disease susceptibility in Caucasians: a meta-analysis.
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR20200321.
9
Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
JAMA Neurol. 2020 Jul 1;77(7):849-862. doi: 10.1001/jamaneurol.2020.0414.
10
The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
Brain Behav Immun. 2018 Oct;73:21-33. doi: 10.1016/j.bbi.2018.07.017. Epub 2018 Jul 21.
本文引用的文献
1
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.
Nat Genet. 2009 Oct;41(10):1094-9. doi: 10.1038/ng.439. Epub 2009 Sep 6.
2
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
Nat Genet. 2009 Oct;41(10):1088-93. doi: 10.1038/ng.440. Epub 2009 Sep 6.
3
Discovering genetic ancestry using spectral graph theory.
Genet Epidemiol. 2010 Jan;34(1):51-9. doi: 10.1002/gepi.20434.
4
Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.
Nat Genet. 2009 Feb;41(2):192-8. doi: 10.1038/ng.305. Epub 2009 Jan 11.
5
Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.
Am J Hum Genet. 2009 Jan;84(1):35-43. doi: 10.1016/j.ajhg.2008.12.008.
6
Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.
Am J Hum Genet. 2008 Nov;83(5):623-32. doi: 10.1016/j.ajhg.2008.10.008. Epub 2008 Oct 30.
7
A genome-wide association study for late-onset Alzheimer's disease using DNA pooling.
BMC Med Genomics. 2008 Sep 29;1:44. doi: 10.1186/1755-8794-1-44.
8
Catmap: case-control and TDT meta-analysis package.
BMC Bioinformatics. 2008 Feb 28;9:130. doi: 10.1186/1471-2105-9-130.
9
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.
Arch Neurol. 2008 Jan;65(1):45-53. doi: 10.1001/archneurol.2007.3. Epub 2007 Nov 12.
10
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Am J Hum Genet. 2007 Sep;81(3):559-75. doi: 10.1086/519795. Epub 2007 Jul 25.
Zotero 插件